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Discovering how histone variants that mark distinct
chromatin regions affect a developmental program
is a major challenge in the epigenetics field. To
assess the importance of the H3.3 histone variant
and its dedicated histone chaperone HIRA, we
used an established developmental model, Xenopus
laevis. After the early rapid divisions exploiting
a large maternal pool of both replicative H3.2 and
replacement H3.3, H3.3 transcripts show a distinct
peak of expression at gastrulation. Depletion of
both H3.2 and H3.3 leads to an early gastrulation
arrest. However, with only H3.3 depletion, defects
occur at late gastrulation, impairing further develop-
ment. Providing exogenous H3.3 mRNAs, but not
replicative H3.2 mRNAs, rescues these defects.
Notably, downregulation of the H3.3 histone chap-
erone HIRA similarly impairs late gastrulation, and
we find a global defect in H3.3 incorporation into
chromatin comparable to H3.3 depletion.We discuss
how specific HIRA-dependent H3.3 deposition is
required for chromatin dynamics during gastrulation.
INTRODUCTION
Proper packaging of eukaryotic DNA into chromatin is required
for functional genome organization (Probst et al., 2009). This
involves the use of a fundamental motif, the nucleosome, which
comprises DNA wrapped around histones. A large number of
variations, including covalent posttranslational modifications
(PTMs) of histones (Jenuwein and Allis, 2001; Turner, 2002),
and histone variant incorporation (Ahmad and Henikoff, 2002b;
Boyarchuk et al., 2011; Loyola and Almouzni, 2007; Sarma and
Reinberg, 2005) defines distinct chromatin landscapes typical
of individual cell types.
In mammals, several H3 variants contribute to these land-
scapes including the replicative forms H3.1 and H3.2, the
replacement variant H3.3, and the centromere-specific H3
variant CenH3 (CENP-A) (Szenker et al., 2011). While the unique
importance of CENP-A for defining the identity of the centromere
is well documented, the respective roles of the closely related730 Cell Reports 1, 730–740, June 28, 2012 ª2012 The AuthorsH3 replicative forms compared to the replacement variant H3.3
are less clear. The expression of replicative H3 peaks in S phase
to supply histones during DNA replication. In contrast, the
replacement variant H3.3, which is expressed throughout the
cell cycle, in quiescent cells, and during distinct stages of differ-
entiation, provides a continuous source of histones (Szenker
et al., 2011). Thus, given the overall similarity of the core particle
containing either type of histone H3 (Tachiwana et al., 2011), one
might assume that these subtypes could functionally substitute
for one another and that incorporation of distinct replicative or
replacement H3 is mainly due to their availability during the
cell cycle.
However, H3.3 is specifically enriched within regions of high
transcriptional activity (Ahmad and Henikoff, 2002a; Chow
et al., 2005; Jin and Felsenfeld, 2006; Jin et al., 2009; Mito
et al., 2005; Schwartz and Ahmad, 2005) and typically marked
by PTMs associated with active transcription such as H3K4
methylation (Hake et al., 2006; Loyola et al., 2006; McKittrick
et al., 2004; Waterborg, 1990). This prompted the hypothesis
that H3.3 could mark transcriptionally active genes, potentially
by promoting transcription and/or as a consequence of tran-
scription. The dynamic properties of tagged H3.3 nucleosomes,
revealed by their unusual sensitivity to salt-dependent disruption
could account for an enhancement in transcriptional activity
(Jin and Felsenfeld, 2007). Interestingly, based on nuclear
transfer and reprogramming experiments in Xenopus laevis,
the memory of an active state is thought to involve H3.3 main-
tenance through a number of cell divisions without ongoing
transcription (Ng and Gurdon, 2008). Indeed, the observed
maintenance of H3.3 is unlikely to involve reactivation of
transcription at each cycle, given that zygotic transcription only
starts after the 12th division in Xenopus (Newport and Kirschner,
1982). Furthermore, the global incorporation of maternal H3.3
onto male DNA upon fertilization in Drosophila (Loppin et al.,
2005) and mice (Torres-Padilla et al., 2006; van der Heijden
et al., 2005) underlines the capacity of this histone to be incorpo-
rated independently of transcription. Obviously, these findings
emphasize a major requirement of H3.3 for reproduction in
both organisms, but do not address the question of its impor-
tance at later stages during development.
A further comparison of H3.3 function during development
in several organisms (Banaszynski et al., 2010; Orsi et al.,
2009; Szenker et al., 2011) highlights the fact that developmental
roles of H3.3 are still poorly defined. In Drosophila, most animals
with mutations of both H3.3 genes survive to adulthood and
appear morphologically normal but are sterile (Ho¨dl and Basler,
2009; Sakai et al., 2009), most likely due to a deficiency in
protamine replacement bymaternal H3.3 ontomale DNA at fertil-
ization (Loppin et al., 2005). In mice, a hypomorphic mutation in
only one of the two H3.3 genes leads to unexplained neonatal
lethality in 50% of cases. Yet surviving animals show not only
subfertility phenotypes but also growth and neuromuscular
defects (Couldrey et al., 1999). Subfertility phenotypes could
reflect defects in paternal genome reprogramming since alter-
ation in protamine replacement by H3.3 is critical for promoting
heterochromatin formation (Santenard et al., 2010). However,
other growth defects suggest additional developmental roles
in vertebrates. Most recently, in human, the observations of
somatic mutations affecting H3 variants or their chaperones in
specific pediatric tumors further emphasize the importance of
considering their role in a developmental context (Schwartzen-
truber et al., 2012; Wu et al., 2012).
Our choice of Xenopus laevis as an ideal model system to
reveal aspects of H3.3 function was guided by four important
criteria. First, the fact that Xenopus sperm chromatin, unlike
Drosophila and mice, retains H3 variants and H4 histones (Kata-
giri and Ohsumi, 1994), enables us to examine H3.3 develop-
mental roles separately from protamine replacement. Second,
the presence of a single representative of the replicative H3 in
Xenopus, related to human H3.2, makes the situation simpler
to analyze. Third, the relatively high level of H3.3 transcripts in
early development compared to adult tissues, as noted in global
gene expression analyses (Baldessari et al., 2005), suggested
additional developmental roles for H3.3. Finally, powerful
in vitro assays using Xenopus egg extracts permit the study of
specific histone deposition pathways, involving dedicated
histone chaperones (Ray-Gallet and Almouzni, 2004).
Indeed, much has been elucidated concerning histone H3
variants’ dynamics and their specific chaperones (De Koning
et al., 2007). For replicative H3, Chromatin Assembly Factor 1
(CAF-1), which comprises three subunits, namely, p150, p60,
and p48, represents the major candidate for deposition in
a DNA synthesis-dependent manner (Smith and Stillman,
1989; Tagami et al., 2004). Concerning H3.3, the early identifi-
cation of HIRA as a histone chaperone promoting H3.3 deposi-
tion onto DNA in vitro using extracts derived from Xenopus
eggs (Ray-Gallet et al., 2002; Tagami et al., 2004) made it the
first candidate for this role in vivo. In Drosophila, HIRA functions
together with the remodeling factor Chromodomain Helicase
DNA-binding protein 1 (CHD1) to promote H3.3 loading onto
male DNA during sperm decondensation (Konev et al., 2007;
Loppin et al., 2005). However, other H3.3 histone chaperones
have been recently identified in mammals, including a complex
composed of the death-associated protein (DAXX) and the
alpha-thalassemia/mental retardation X-linked syndrome
protein (ATRX) (Drane´ et al., 2010; Goldberg et al., 2010; Lewis
et al., 2010). The recent analysis of de novo histone H3 incor-
poration in cultured cells using the SNAP tagging system
advanced the notion that the HIRA deposition pathway could
work at any time during the cell cycle to ensure chromatin
integrity whenever a failure in histone deposition occurs (Ray-
Gallet et al., 2011). How such a requirement may become crit-ical during the development of a whole organism has yet to be
established.
In this paper, we studied H3.3 during Xenopus development
and found that it is required for late gastrulation to proceed.
Importantly, this requirement cannot be substituted by replica-
tive H3.2. Similarly, the HIRA chaperone proved critical at late
gastrulation, and HIRA morphants showed chromatin defects
associated with reduced H3.3 levels and higher sensitivity to
MNase digestion. We discuss how HIRA-mediated H3.3 deposi-
tion is required to meet the needs of chromatin dynamics to
properly complete gastrulation in Xenopus.
RESULTS
H3.3 Is Specifically Required during Gastrulation
We first explored the expression profile of H3 variants both at
the RNA and protein levels during Xenopus development. We
found both by northern blot and in situ hybridization that
transcripts corresponding to both variants are maternally stored
in the egg with a distinct peak for H3.3 at gastrulation (Figures
S1A and S1B). This was complemented by our analysis at the
protein level using a Triton acetic acid urea gel (Zweidler,
1978), which shows that both H3.2 and H3.3 are present at
similar levels in eggs through the mid blastula transition (MBT)
stage (Figure S1C), suggesting an equal use of both maternal
proteins prior to MBT. After this transition, H3.3 protein levels
decreased relative to H3.2 to reach a level comparable to that
in somatic cells, where the replicative H3 largely dominates as
observed in HeLa cells (Loyola et al., 2006). These observations
prompted us to explore whether H3.3 could have a particular
contribution at the time of gastrulation during Xenopus early
development. To address the functional importance of H3
proteins, we designed specific antisense morpholino oligo-
nucleotides that prevent translation of target transcripts when
injected into embryos. We first tested our morpholinos (MO)
for specificity in oocytes (not shown) and then assessed their
efficiency in embryos. Using soluble fractions derived from
embryos injected with the respective morpholinos, we show
that MO H3.3 specifically diminishes H3.3 while MO H3 targets
both H3.2 and H3.3 (Figure 1A). This is shown by western blot
analysis usingmonoclonal antibodies whose specificity for either
H3.2 or H3.3 was confirmed (Figure S2A). In MO H3 treated
embryos, we observed an early gastrulation developmental
arrest (Figure 1B and Movie S1). This is consistent with the
prevention of all new H3 expression while exhausting the
maternal histone proteins (Laskey et al., 1978). Of note, this
arrest is comparable to a CAF-1 p150 MO (Figure S2B) and
occurs later than the one observed when a dominant negative
form of CAF-1 interferes with chromatin assembly prior to the
MBT in Xenopus (Quivy et al., 2001). In contrast, the specific
knockdown of H3.3 enabled further developmental progression
in early gastrulation but revealed later defects (Figure 1B and
Movie S1). Embryos surviving to the tailbud stage show severe
developmental defects including an open blastopore, spina
bifida, and a shortened anteroposterior axis (Figure 1B, white
arrow). The penetrance and severity of the phenotype was dose
dependent (Figure S3A), but never matched the effect seen
with the morpholino targeting both H3.2 and H3.3 (MO H3).Cell Reports 1, 730–740, June 28, 2012 ª2012 The Authors 731
Figure 1. Importance of H3.2 and H3.3
during Early Development
(A) Specificity of H3.3 and H3 morpholinos. (Left)
The scheme shows injections of indicated mor-
pholinos (MO) in fertilized eggs (13.8 ng). After
incubation to reach stage 12 in controls, 80
embryos were used to prepare soluble fractions
for western blot analysis. (Right) Results used
a 2-fold dilution series (gradient bar) with the
highest quantity being equivalent to three em-
bryos, and detection with indicated antibodies
(see also Figure S2A). Anti-b actin and memcode
staining served as loading controls.
(B) H3.3 and H3 downregulation leads to distinct
phenotypes. The scheme shows injections of
indicated MO (4.6 ng) in one cell of 2-cell stage
embryos. We kept embryos at 18C and acquired
images at the indicated stages (using control
embryos as a reference). White arrows point to
the gastrulation defects in H3.3 morphants. In the
bottom panel, we show a broader coverage of
the gastrulation time period (stages 11–13) with
eight distinct time points (see also Movie S1).
Scale bar: 1 mm.
See also Figures S1, S2, and S3.Closer inspection revealed a slowdown of morphogenetic
movements leading to embryos that failed to close their
blastopore correctly at the end of gastrulation and that shed
cells through the open blastopore (Figure 1B, white arrows, and
Movies S1 and S2).
To ask whether this gastrulation phenotype simply reflects
a general limitation in availability of H3 or is specifically due to
H3.3 loss, we designed a rescue experiment by injecting MO
H3.3 together with control GFP, H3.2-HA, or H3.3-HA mRNAs
(Figure 2C). First, we verified that both H3.2 and H3.3 tagged
constructs could be effectively incorporated into chromatin
(Figure 2A). Moreover, to eliminate the possibility that depletion
of the variants may affect the chaperones, we documented
the expression of the H3.2 and H3.3 histone chaperones,
CAF-1 and HIRA, in the embryos throughout development
(Figure S3B), and verified that they remain unaffected in
gastrulae upon downregulation of H3.3 (Figure 2B). These data
establish that both tagged H3.2 and H3.3 are functional, and732 Cell Reports 1, 730–740, June 28, 2012 ª2012 The Authorsthat depletion of H3.3 does not affect
H3-specific chaperones. The observation
of embryos at the early tail-bud stage
(stage 25) revealed a rescue in 62% of
MO H3.3 treated embryos with the coin-
jection of H3.3 transcripts, supporting
the specificity of the observed phenotype
(Figure 2C). Notably, coinjection of H3.2
mRNAs failed to rescue gastrulation
defects in H3.3-deficient embryos (Fig-
ure 2C). Comparable protein levels for
GFP, H3.2, and H3.3 in injected embryos
confirmed that the lack of rescue could
not reflect a defect in H3.2 mRNAs
translation (Figure 2C). Taken together,our data support a model where there is a specific requirement
for H3.3 for proper gastrulation that cannot be bypassed by
H3.2 overexpression.
H3.3-Mediated Defects at Gastrulation and Abnormal
Expression of Late Mesoderm Markers
Among the important events occurring during gastrulation,
mesoderm induction represents a major developmental step
that involves activating the expression of a series of genes.
The induction starts at stage 9.5, and accumulation of specific
transcripts is diagnostic of a successful process. As a reference,
we first examined the gene Xenopus brachyury (Xbra), a tran-
scription factor whose transcripts mark the marginal zone,
a region containing cells destined to become mesoderm, at
the gastrula stage (stage 11) (Herrmann and Kispert, 1994;
Showell et al., 2004). Following injection with MO H3.3 in one
cell of 4 cell-stage embryos, we found by in situ hybridization
that Xbra expression is clearly reduced at gastrulation and
Figure 2. Additional H3.2 Cannot Bypass the Need
for H3.3
(A) HA tagged-H3.2 and -H3.3 proteins can be incorpo-
rated into chromatin. (Left) The scheme shows injections
of indicated mRNA (500 pg) in one cell of 2-cell stage
embryos. After incubation to reach stage 11 in controls, 50
embryos were used to prepare chromatin for western blot
analysis. (Right) Results used a 2-fold dilution series
(gradient bar) with the highest quantity being equivalent to
two embryos, and detection with indicated antibodies.
Anti-H4 served as a loading control.
(B) Expression of histone chaperones in H3.3-deficient
embryos. (Left) The scheme shows injections of H3.3 MO
(23 ng) in fertilized eggs. After incubation to reach stage 14
in controls, 40 noninjected () and 40 injected (MO H3.3)
embryos were used to prepare soluble fractions for
western blot analysis. (Right) Results used a 2-fold dilution
series (gradient bar) with the highest quantity being
equivalent to three embryos, and detection with indicated
antibodies. Anti-b-actin served as a loading control. We
note that H3.3 downregulation leads to overexpression of
HIRA in soluble fractions.
(C) H3.3 but not H3.2 mRNAs can rescue the H3.3-
deficient phenotype. The scheme shows injections of
indicatedMO (46 ng for CTL and 4.6 ng for H3.3) in one cell
of 2-cell stage embryos followed by a second injection
with indicated mRNAs (2 ng). After incubation to reach
stage 25 in control embryos, three embryos served for
image acquisition (top) and followed by total protein
extraction for western blot analysis (bottom). (Top) We
scored the viability for 30 embryos (percentage is shown).
Scale bar: 1 mm. (Bottom) We loaded the equivalent of
0.5 and 0.25 embryo (gradient bar) and revealed with
indicated antibodies. Anti-tubulin served as a loading
control.
See also Figures S2 and S3.throughout development when H3.3 is depleted (Figure 3A,
white arrows, Figure S3C). We thus conclude that H3.3 is critical
for the proper expression of a mesodermal gene, Xbra.
We then analyzed the expression levels of a larger series of
lineage marker genes after depletion of H3.3 in embryos
harvested at stage 11, by reverse transcription followed by
quantitative PCR (qRT-PCR) (Figures 3B and S4A). First, weCell Reports 1,considered genes involved in early mesoderm
induction, which are in part responsible for
Xbra expression (Heasman, 2006), including
genes encoding members of the tranforming
growth factor-beta (TGF-b) family such as
Derrie`re, or proteins of the nodal family (Xeno-
pus nodal related genes, Xnrs). For a compar-
ison, we also examined transcription factors in-
volved in endoderm formation such as Sox17,
Mixer, and Mix1 (Heasman, 2006). We found
that the expression level of endodermal genes
and mesodermal-inducing factors such as
Xnr2 and Derrie`re did not significantly change
in H3.3 morphant embryos when compared to
control embryos (Figure 3B and S4A). We then
examined the expression of genes directly
implicated in the formation of the mesodermallayer, including Xbra, eFGF, xWnt11,Myf5, andMyoD (Heasman,
2006). Importantly, we confirmed the defect in Xbra expression
levels, in parallel with the downregulation of eFGF, Wnt11,
Myf5, and MyoD (Figures 3B, S4A, and S4B). This is in accor-
dance with the facts that eFGF and Xbra cross-activate each
other’s expression during the establishment of the mesoderm
(Isaacs et al., 1994) and that MyoD expression is regulated by730–740, June 28, 2012 ª2012 The Authors 733
Figure 3. The Early Mesodermal Marker Xbra Is
Misregulated in the Absence of H3.3
(A) Xbra expression pattern defects in H3.3 morpholino
injected embryos. The scheme shows injections of indi-
cated MO (69 ng of CTL, 4.6 ng of either H3.3 or mutH3.3
MO) in one cell of 4-cell stage embryos. After incubation to
reach the indicated stages in controls, we fixed embryos
and performed whole mount in situ hybridization with an
Xbra probe. White arrows indicate the injected part and
arrowheads the noninjected part of H3.3 morphants.
Scale bar: 1 mm.
(B) Expression level of developmental genes. The scheme
shows injections of indicatedMO (9.2 ng) in fertilized eggs.
After incubation to reach stage 11 (gastrula) in controls,
embryos were used to prepare total RNA extracts and
were analyzed by qRT-PCR of indicated genes (see also
Figure S4A). We represent the expression of a series of
genes in H3.3 morphants compared to controls. Red
boxes show genes that are significantly downregulated
and gray boxes genes whose expression is not sig-
nificantly affected. Statistical test from 8 independent
experiments performed in duplicates: paired Student’s
t test, p value < 0.05. See also Figure S4.eFGF and Xbra (Fisher et al., 2002). Taken together, our data
show that while early mesoderm inducing signals are largely
unaffected, abnormal expression of later mesodermal differenti-
ation markers occurs in H3.3 morphants.
Interestingly, we found both by qRT-PCR and in situ hybridiza-
tion that H3.3 downregulation also affects the expression of
some genes implicated in the dorsal neural regulatory network
including Chordin, ADMP, and the downstream proneural genes
Otx2 and Sox2 (Heasman, 2006), but not Sip1, a known inhibitor
of Xbra (Lerchner et al., 2000; Verschueren et al., 1999) (Figures
S4A and S4B). However, ventral proepidermal genes such as734 Cell Reports 1, 730–740, June 28, 2012 ª2012 The AuthorsxVent1 and xVent2 were not significantly
affected (Figure S4A). These data support
a model whereby loss of H3.3 impacts a set of
genes that should normally be activated during
mesoderm and neuroectoderm induction in
the embryos at a similar time. This phenotype
could potentially be due to either a defect in
the mesoderm and/or neuroectoderm induction
signals to specifically activate target genes, or,
alternatively, it may be a consequence of the
fact that activated genes at this particular
stage become more dependent on H3.3 for
the maintenance of their expression.
H3.3 Is Dispensable for Initiation
of Mesoderm Induction Yet Critical
for Cell Viability
To test the hypothesis whereby the mesoderm
induction would be impaired in H3.3morphants,
we employed animal cap assays to investigate
whether H3.3 morphants could respond to
exogenous mesoderm-inducing factors. Using
activin as a mesoderm-inducing growth factor
to stimulate animal cap elongation (Suzukiet al., 1994), we did not observe a statistically meaningful differ-
ence between H3.3 morphants and controls when treating
animal caps either for 90 min (Figure 4A, 5 ng) or 24 hr (data
not shown). This is in contrast to the dramatic effect observed
with the dominant negative form of Xbra, Xbra-EnR (Conlon
et al., 1996) (Figures 4A and S5A). Interestingly, when we
increased the amount of MOH3.3 to try to exacerbate a potential
elongation defect, the animal caps instead disintegrated
(Figure 4A, 9.2 ng). When examining H3.3 morphants more
closely at the end of gastrulation, we observed white cells
shed outside the embryos, a first indication of cell death
Figure 4. H3.3 Downregulation Does Not Affect
Animal Caps Elongation upon Mesoderm Induc-
tion but Leads to Cell Death
(A) Animal Cap assay using MO H3.3 treated embryos.
The scheme shows injections in both cells of 2-cell
stage embryos with indicated MO [2.5 ng/cell (= 5 ng) or
4.6 ng/cell (= 9.2 ng)] or with Xbra-EnR mRNA [250 pg/cell
(= 500 pg)], a dominant-negative form of Xbra as a nega-
tive control. After incubation to reach stage 8 in controls,
we dissected animal caps in each case for incubation with
or without activin (5 ng/ml) for 1.5 hr, and cultured them
until sibling embryos reached the neurula stage. For the
low MO dose (5 ng), we show an inset of one represen-
tative animal cap elongation at the same magnification
scale as the other panels. Scale bar: 1 mm.
(B) Analysis of H3.3 morpholino injected embryos
throughout development. The scheme shows injections of
indicated MO (4.6 ng) in one cell of 2-cell stage embryos.
We followed development at 18C of one control (white
box) and five H3.3 morphants with acquisition from the
vegetative pole (see also Movie S2). Here are three time
points: 64 cells, gastrula, and neurula stage. White arrows
indicate the apoptotic cells observed at the end of the
gastrulation. Scale bar: 1 mm.
(C) TUNEL assay of MO H3.3 treated embryos. We in-
jected the indicated MO (4.6 ng) in one cell of 2-cell stage
embryos and performed a TUNEL assay when controls
embryos reached the neurula and tailbud stages. White
arrows indicate the TUNEL positive cells in the injected
side of H3.3 morphants. The majority of white apoptotic
cells comes off the embryos at the beginning of the
experimental procedure that involves dechorionization.
Scale bar: 1 mm.
See also Figure S5.(Figure 4B and Movie S2). We confirmed cell death in H3.3
morphants both at the neurula and tailbud stages (in contrast
to control embryos, Figure 4C) by a Terminal deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL) assay detecting
DNA fragmentation (Hensey and Gautier, 1997). Taken together,
our data show that in an animal cap assay using exogenous
activin, the early response to mesoderm induction does occur
in H3.3 morphants, but ultimately a strong depletion leads to
cell death. These data indicate that early events can take place,
but maintenance of the activation is impaired and downregu-
lation of H3.3 leads to cell death when gastrulation fails to
progress.
HIRA Is Required for Loading H3.3 and Late Gastrulation
We then asked whether the requirement for H3.3 could relate to
a specific need for H3K4 methylation, given that this mark is
specifically enriched on H3.3 nucleosomes that accumulate at
actively transcribed loci. Global levels of H3K4 methylation are
severely reduced when the highly conserved WD40-repeatCell Reports 1,protein 5 (WDR5), amajor methyl K4-associated
factor, is downregulated in Xenopus embryos
(Wysocka et al., 2005), leading to develop-
mental defects in tadpoles (Figure S5B).
However, WDR5 knockdown embryos did not
show any gastrulation defects resemblingH3.3 downregulation (Figure 5B) and Xbra expression was
unaffected (Figure 5C). Thus, the requirement for H3.3 at gastru-
lation cannot relate directly to H3K4 methylation promoted by
WDR5.
We then assessed whether loss of HIRA could disrupt
Xenopus development in a manner comparable to H3.3. Injec-
tion of morpholinos specifically downregulating HIRA proteins
in embryos (Figure 5A) led to late gastrulation defects similar to
the ones observed in H3.3-deficient embryos (Figure 5B – white
arrows, Figure S3A for different doses of MO). In addition,
in situ hybridization of HIRA morphants showed a comparable
downregulation of Xbra (Figures 5C and S3C). We conclude
that HIRA plays a critical role during late gastrulation in a manner
that resembles the H3.3 requirement. This parallel suggested
a possible connection between HIRA and H3.3 deposition that
warranted further exploration.
Interestingly, in vitro nucleosome assembly assays using
Xenopus egg extracts supported a critical role for HIRA in
a deposition pathway independent of DNA synthesis using730–740, June 28, 2012 ª2012 The Authors 735
Figure 5. HIRA Downregulation Resembles the H3.3 Phenotype
(A) Specificity of HIRA morpholinos. (Left) The scheme shows injections of
HIRA MO (92 ng) in fertilized eggs. After incubation to reach stage 11 in
controls, 40 noninjected () and 40 injected (MO HIRA) embryos were used to
prepare soluble extracts for western blot analysis. (Right) Results used a 2-fold
dilution series (gradient bar) with the highest quantity being equivalent to three
embryos, and detection with a HIRA antibody. Anti-b-actin and memcode
staining served as loading controls.
(B) Downregulation of HIRA but not WDR5 leads to gastrulation defects. We
injected the indicated MO (46 ng) in one cell of 2-cell stage embryos. We
acquired images when controls were at the indicated stages. White arrows
indicate the gastrulation defects observed in HIRA morphants. In the bottom
panel, we show a broader coverage of the gastrulation time period (stages 11
to 13) with eight distinct time points (see also Movie S1). Scale bar: 1 mm.
(C) Xbra mRNA in situ hybridization in HIRA- and WDR5-deficient embryos.
We injected the indicated MO (69 ng for CTL or WDR5, 46 ng for either HIRA
or mutHIRA) in one cell of 4-cell stage embryos. After incubation to reach
the indicated stages in controls, we fixed injected embryos and performed
whole-mount in situ hybridization with an Xbra probe. White arrows indicate
the injected part and arrowheads the noninjected part of HIRA morphant
embryos. Scale bar: 1 mm.
See also Figures S3 and S5.depletion experiments (Ray-Gallet et al., 2002) and as shown
here by neutralization with antibodies (Figure 6A). We thus tested
if HIRAmorphants showed defects in their chromatin particularly
with respect to H3.3 incorporation. Given the comparable
phenotypes between H3.3 and HIRA morphant embryos, an736 Cell Reports 1, 730–740, June 28, 2012 ª2012 The Authorsinterdependency between them had to be considered. We thus
compared their chromatin status in parallel, and found that in
both H3.3 and HIRA morphants, the amount of H3.3 in the chro-
matin is similarly affected (Figure 6B). We thus showed a direct
andmajor impact of HIRA on H3.3 in vivo. Furthermore, the anal-
ysis of chromatin sensitivity to MNase digestion in H3.3 or HIRA
morphants showed remarkable similarity in its increased diges-
tion relative to control embryos (Figure 6C). Taken together,
these data support a view where HIRA is necessary to ensure
H3.3 deposition and this would be critical at the time of gastrula-
tion. We thus propose that a mechanism involving HIRA for H3.3
deposition, independent of DNA synthesis, is critical at the time
of gastrulation.
DISCUSSION
Our data in Xenopus demonstrate the unique importance of the
H3.3 variant at gastrulation, a critical transition during vertebrate
development marked by major changes in cell cycle and devel-
opmental programs. Importantly, while themorpholino approach
in Xenopus could unveil a time when H3.3 first becomes critical,
other stages of development and cell differentiation could
equally require H3.3 deposition. Thus, these findings should be
considered with a broad implication.
A Distinct Role for H3.3 at Late Gastrulation
Remarkably, the distinct late gastrulation defects arising after
depletion of H3.3 with morpholinos could not be overcome by
providing exogenous H3.2 mRNAs. Thus, the two types of H3
variants are not easily interchangeable at this critical develop-
mental stage. This argues for a specific requirement for H3.3
and/or its deposition mode rather than a mere histone H3 gene
dosage deficiency. Similarly, in Tetrahymena, extra provision of
replicative H3 cannot overcome the absence of H3.3 (Cui
et al., 2006) and H3.3A knockout mice are neonatal lethal (Coul-
drey et al., 1999). Intriguingly, though sterile, most Drosophila
embryos lacking H3.3 survive until adulthood. However this
involves an upregulation of the replicative histone H3 transcripts
to compensate for the lack of H3.3 (Ho¨dl and Basler, 2009; Sakai
et al., 2009). It is thus possible that the overexpression of one
variant in the absence of the other enables Drosophila embryos
to survive. This would support the view that the variant itself may
not be the most critical parameter but it would rather be the
ability to exploit different deposition pathways and correspond-
ing chaperones.
The Impact of H3.3 on Transcriptional Program at Late
Gastrulation
Here, following depletion of H3.3, clear defects occur at late
gastrulation with a failure of blastopore closure and increased
cell death. Importantly, the expression of nodal-related genes,
which are fundamental for both mesoderm and endoderm
formation in early gastrula embryos (Watabe and Miyazono,
2009), were unaffected by the lack of H3.3. Thus, the importance
of H3.3 does not equally impact simply any transcribed gene,
but rather relates to their activation timing. This is consistent
with the downregulation after H3.3 depletion of the mesodermal
marker, Brachyury (Xbra), one of the many genes controlled by
Figure 6. HIRA Is Critical for H3.3 Assembly
during Early Development
(A) Nucleosome assembly independent of DNA
synthesis requires HIRA in vitro. The scheme
shows a nucleosome assembly assay indepen-
dently of DNA synthesis using Xenopus high
speed egg extracts (HSEs). We incubated circular
DNA plasmids with HSE (5 ml) during the indicated
times together with antibodies targeting xHIRA
(aHIRA), PBS (CTL), or preimmune serum (not
shown). After deproteinization, we analyzed
plasmid DNA supercoiling by electrophoresis on
agarose gel stained with ethidium bromide. Input
DNA run in parallel (first lane on the left, 0 min)
and migration positions of DNA plasmid form I
(supercoiled), form II (nicked circular), form Ir
(closed circular) are indicated.
(B) HIRA downregulation affects the level of H3.3
in the chromatin. The scheme shows injections
of indicated MO (18.4 ng for H3.3 and 138 ng for
HIRA) in fertilized eggs. After incubation to reach
stage 14 in controls (), 40 embryos in each case
were used to prepare soluble and chromatin
fractions for western blot analysis. Results used
a 2-fold dilution series (gradient bar) with the
highest quantity being equivalent to three em-
bryos, and detection with antibodies. Anti-bactin
andmemcode staining served as loading controls.
We note that H3.3 downregulation leads to over-
expression of HIRA in soluble fractions.
(C) MNase digestion profile of H3.3 and HIRA MO
injected embryos. We injected 18.4 ng of H3.3 and
138 ng of HIRA MO in fertilized eggs. After incu-
bation to reach stage 14 in noninjected controls
(CTL1 and 2), 40 embryos in each case were used
to prepare nuclei that we subjected to MNase
digestion for increasing indicated incubation
times. For each time point, we purified the result-
ing DNA fragments from the equivalent of 1.5
embryos to be analyzed by electrophoresis on
agarose gel stained with ethidium bromide.
Densitometric profiles of the 1 min digestion
products are shown on the right.the nodal/activin signaling pathway (Latinkic et al., 1997). In
addition to Xbra and eFGF, we also found that Myf5, as well as
a downstream master gene in muscle differentiation, MyoD,
are also downregulated. In agreement with these observations,
a recent report showed that H3.3 histone deposition occurs at
the MyoD promoter in a cellular model reproducing myogenic
transcriptional activation (Yang et al., 2011). This could reflect
a direct impact of H3.3 on transcription as proposed (Elsaesser
et al., 2010), as well as the necessity to incorporate more H3
outside S phase when these genes are transcribed. These two
possibilities are not mutually exclusive, and each should be
considered. The presence of H3.3 at regions with high histone
turnover, including promoters and regulatory elements (Gold-
berg et al., 2010; Ray-Gallet et al., 2011), could contribute to
maintaining particular settings. In particular, in the context of
chromatin changes during early development in Xenopus, other
histone variants (Almouzni et al., 1994; Dimitrov et al., 1993)
should be considered, especially given the crosstalk between
H3.3 and H2A.Z promoting transcription in cellular models (Jinand Felsenfeld, 2007). First, somatic H1, whose overexpression
reduces mesoderm-specificMyoD induction during gastrulation
(Steinbach et al., 1997; Vermaak et al., 1998), could antagonize
H3.3, as suggested by the anticorrelation between H1 and
H3.3 distribution genome-wide (Braunschweig et al., 2009).
Second, H2A.Z, whose depletion in Xenopus laevis led to gastru-
lation defects (Ridgway et al., 2004), could function together
with H3.3 to antagonize H1 and establish permissive chromatin
settings. These specific chromatin settings, beyond having an
impact on transcriptional maintenance, could also contribute
to maintaining chromatin integrity and thereby impact cell
viability.
The Importance of a HIRA-Dependent H3.3 Deposition
Pathway to Establish/Maintain Specific Chromatin
States
The critical requirement of H3.3 may reflect the need for histone
incorporation to replace histones at any sites presenting chro-
matin defects/nucleosome disruption (De Koning et al., 2007).Cell Reports 1, 730–740, June 28, 2012 ª2012 The Authors 737
Recent findings showed that HIRA could enable nucleosomal
free DNA to be reassembled genome wide when the CAF-1-
dependent deposition of replicative H3 failed (Ray-Gallet et al.,
2011). During gastrulation, when the length of gap phases are
becoming significant, replicative chromatin assembly will not
suffice to re-establish proper chromatin organization, and this
may become evenmore critical at highly induced gene loci (New-
port and Kirschner, 1982). A decrease in nucleosome density
beyond a threshold could lead to cell death, possibly through
mitotic catastrophe.While we could show that H3.3was critically
required during development, it was important to consider
histone chaperones as an important aspect of histone variant
dynamics (De Koning et al., 2007). Downregulation of HIRA
proved critical during late gastrulation in our experiments in
a manner paralleling the defects upon H3.3 downregulation.
This is illustrated not only at the developmental level, but most
importantly at the chromatin level, where we could detect
decreased H3.3 levels and increased sensitivity toMNase diges-
tion, similar to direct H3.3 depletion. Thus, we provide here
a clear interdependency in the embryo between HIRA and
H3.3, which both affect chromatin at a global level. Further
studies will be needed to determine how the complex histone
chaperone network acts with H3.3 during development.
Conceptually, the fact that a mechanism acting at the chro-
matin level and linked to cell cycle can both integrate changes
in transcription and help maintain a transcriptional program
provides an ideal regulatory means during normal development
to control the balance between cell differentiation and viability.
In pathological situations where H3 variants are mutated
(Schwartzentruber et al., 2012; Wu et al., 2012), it will be impor-
tant to evaluate these requirements to elucidate their contribu-
tion to tumor progression.EXPERIMENTAL PROCEDURES
Embryo Manipulation
We used Xenopus laevis adults from Centre Ressource Biologie ‘‘Xenope’’ for
experiments approved by the Comite´ d’Ethique en matie`re d’Expe´rimentation
Animale Ile de France Paris 1. We prepared embryos as in (Almouzni et al.,
1994; Roche et al., 2006) and staged them according to (Nieuwkoop and
Faber, 1967). Procedures for the animal cap assay (Green, 1999) involved
dissecting animal caps from stage 8 embryos, and incubating with Activin
(R&D systems, catalog #338-AC-010, 5 ng/ml) for 90 min, followed by transfer
in Activin-free medium for further incubation until sibling embryos had reached
the neurula stage. Assays for TUNEL on embryos were performed as
described (Hensey and Gautier, 1997).Whole-Mount In Situ Hybridization
We performed whole-mount RNA in situ hybridizations as described (Sive
et al., 2000). We revealed using BM purple substrate (Roche Diagnostics)
and acquired images with a LEICA MZ FLIII stereomicroscope. When
indicated, we performed cross sections on fixed embryos before the in situ
hybridization experiment. See Extended Experimental Procedures for details
on plasmids and probes.Morpholino and mRNA Microinjection
We microinjected embryos using a Drummond Nanoject injector (Drummond
Scientific, Broomall, PA) with an injection volume set from 4.6 to 27.6 nl to
deliver the appropriate quantity of MO or mRNA (as indicated). See Table S1
for MO sequences (Gene Tools, LLC) that anneal to the initiation region738 Cell Reports 1, 730–740, June 28, 2012 ª2012 The Authors(start codon) of targeted mRNAs; see Extended Experimental Procedures for
details on in vitro-transcribed specific 50 capped mRNAs.
Protein Extracts Preparation and Western Blotting
We prepared total protein extracts from embryos using the CelLytic Express
reagent (Sigma-Aldrich). For soluble and chromatin (oligonucleosomes)
fractionations, we adapted the following protocol (Kornberg et al., 1989),
with modifications (see Extended Experimental Procedures). We analyzed
protein samples by electrophoresis either on Triton Acetic acid Urea (TAU)
gels to separate histone subtypes (Zweidler, 1978), or on 4%–12% NuPAGE
SDS-PAGE gels (Life Technologies). We tested H3.2 (van der Heijden et al.,
2005) and H3.3 ((Drane´ et al., 2010); Abnova H00003021-M01) antibodies for
specificity using wheat germ extracts (Promega, # L4380).
Supercoiling Assay and MNase Treatment
We carried out supercoiling assays using High Speed Egg extracts (HSEs) as
described (Ray-Gallet and Almouzni, 2004), and added xHIRA antibodies
(aHIRA), PBS (control) or preimmune serum (not shown) in variable volumes
to monitor their blocking efficiency.
We carried out limited digestions with MNase (Nuclease S7; Micrococcal
nuclease, #10107921001, Roche Diagnostics) on nuclei isolated from stage
14 embryos according to a modified protocol from (Kornberg et al., 1989).
See Extended Experimental Procedures for details.
RNA Extraction, Northern Blotting, and qRT-PCR
We isolated total RNA from embryos using the TRIZOL reagent (Life Technol-
ogies) or the RNeasy Mini Kit (QIAGEN) to either perform a northern blot
analysis ((Brown et al., 2004), see supplemental information for probe details)
or generate first-strand cDNA with random primers (Superscript III Reverse
Transcriptase Kit - Life Technologies). We used cDNA to carry out quantitative
PCRs with either the 7500HT Fast Real Time PCR System (Applied Biosys-
tems) or the Light Cycler System (Roche Diagnostics). We used the SYBR
Green PCR Master Mix (Applied Biosystems) and primer sequences are listed
in Table S2. For each experiment, biological and technical triplicates enabled
statistical analysis using a Student’s t test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, five
figures, two tables, and two movies and can be found with this article online
at doi:10.1016/j.celrep.2012.05.006.
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